Aska Pharmaceutical Company Limited (4514) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Aska Pharmaceutical Company Limited Company Snapshot

Business Description:

Aska Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector. ASKA Pharmaceutical Co., Ltd. is a Japan-based company mainly engaged in the medical product industry. The Company operates in two business segments. The Pharmaceutical Products segment is engaged in the manufacture, purchase and sale of pharmaceutical products. The Others segment is involved in the provision of clinical examination and test services, the sale of medical equipment, as well as the sale of food products. As of March 31, 2011, the Company had two subsidiaries and three associated companies. In September 2010, the Company completed the liquidation of its consolidated subsidiary, Gureran Business Create Co., Ltd. In our complete report available for purchase the company is compared to: Towa Pharmaceutical Company Limited, Torii Pharmaceutical Co., Ltd. and Zeria Pharmaceutical Co., Ltd..

Aska Pharmaceutical Company Limited

Stock Data:

Recent Stock Performance:

Current Price (2/10/2012): 490.00
(Figures in Japanese Yen)

1 Week	-0.4%	13 Weeks	7.5%

4 Weeks	-2.8%	52 Weeks	-19.5%

Aska Pharmaceutical Company Limited Key Data:

Ticker:	4514	Country:	JAPAN

Exchanges:	TYO	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2011 Sales	45,849,000,000 (Year Ending Jan 2012).	Employees:	930

Currency:	Japanese Yen	Market Cap:	13,799,649,990

Fiscal Yr Ends:	March	Shares Outstanding:	28,162,551

Share Type:	Common	Closely Held Shares:	8,100,000

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.